Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Sanson

Showing results (91-100 of 290) with videos related to

Pageof 29
Sort By:
Journal of Neuro-Oncology|April 6, 2007
Association of telomerase gene hTERT polymorphism and malignant gliomasCatherine Carpentier, Julie Lejeune, Florent Gros, et al.
Nature Reviews. Neurology|June 11, 2014
MGMT testing--the challenges for biomarker-based glioma treatmentWolfgang Wick, Michael Weller, Martin van den Bent, et al.
Plos One|January 3, 2009
NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomasMagdalena Benetkiewicz, Ahmed Idbaih, Pierre-Yves Cousin, et al.
Journal of Neuro-Oncology|July 31, 2015
Differential gene methylation in paired glioblastomas suggests a role of immune response pathways in tumor progressionAgustí Alentorn, Alberto Durán-Peña, Andigoni Malousi, et al.
Neuro-Oncology|February 1, 2012
A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054)Roy Rampling, Marc Sanson, Thiery Gorlia, et al.
Oncotarget|December 30, 2014
Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastropheElodie A Pérès, Aurélie N Gérault, Samuel Valable, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|January 10, 2022
Automated Acquisition Planning for Magnetic Resonance Spectroscopy in Brain CancerPatrick J Bolan, Francesca Branzoli, Anna Luisa Di Stefano, et al.
Journal of Neurosurgery|January 1, 2003
Analysis of loss of chromosome 10q, DMBT1 homozygous deletions, and PTEN mutations in oligodendrogliomasMarc Sanson, Pascal Leuraud, Lucinda Aguirre-Cruz, et al.
BMC Cancer|May 22, 2013
Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastasesAhsan Siraj, Virginie Desestret, Martine Antoine, et al.
Journal of Neuro-Oncology|November 27, 2015
TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomasUmberto Nencha, Amithys Rahimian, Marine Giry, et al.
Pageof 29

Showing results (91-100 of 290) with videos related to

Sort By:
Pageof 29
Journal of Neuro-Oncology|April 6, 2007
Association of telomerase gene hTERT polymorphism and malignant gliomasCatherine Carpentier, Julie Lejeune, Florent Gros, et al.
Nature Reviews. Neurology|June 11, 2014
MGMT testing--the challenges for biomarker-based glioma treatmentWolfgang Wick, Michael Weller, Martin van den Bent, et al.
Plos One|January 3, 2009
NOTCH2 is neither rearranged nor mutated in t(1;19) positive oligodendrogliomasMagdalena Benetkiewicz, Ahmed Idbaih, Pierre-Yves Cousin, et al.
Journal of Neuro-Oncology|July 31, 2015
Differential gene methylation in paired glioblastomas suggests a role of immune response pathways in tumor progressionAgustí Alentorn, Alberto Durán-Peña, Andigoni Malousi, et al.
Neuro-Oncology|February 1, 2012
A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054)Roy Rampling, Marc Sanson, Thiery Gorlia, et al.
Oncotarget|December 30, 2014
Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastropheElodie A Pérès, Aurélie N Gérault, Samuel Valable, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|January 10, 2022
Automated Acquisition Planning for Magnetic Resonance Spectroscopy in Brain CancerPatrick J Bolan, Francesca Branzoli, Anna Luisa Di Stefano, et al.
Journal of Neurosurgery|January 1, 2003
Analysis of loss of chromosome 10q, DMBT1 homozygous deletions, and PTEN mutations in oligodendrogliomasMarc Sanson, Pascal Leuraud, Lucinda Aguirre-Cruz, et al.
BMC Cancer|May 22, 2013
Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastasesAhsan Siraj, Virginie Desestret, Martine Antoine, et al.
Journal of Neuro-Oncology|November 27, 2015
TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomasUmberto Nencha, Amithys Rahimian, Marine Giry, et al.
Pageof 29